Gara Jalqabaatti › Dukkana Dhiigaa › North Carolina › Durham
Qorannoo klinikaalii Dukkana Dhiigaa Durham, NC keessatti
Qorannoo 16 Dukkana Dhiigaa f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Namoota walitti qabaa jiraSadarkaa 3
- Duke Cancer Center ( Site 0028), Durham
- University of North Carolina at Chapel Hill ( Site 0040), Chapel Hill · Miili 10 fagaatti
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Durham VA Medical Center, Durham
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Namoota walitti qabaa jiraSadarkaa 3
- Quetzal Site 27, Chapel Hill · Miili 10 fagaatti
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Namoota walitti qabaa jiraSadarkaa 3
- Duke University, Durham
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Namoota walitti qabaa jiraQorannoo ilaalaa
- Duke University Medical Center, Durham
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Namoota walitti qabaa jiraSadarkaa 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · Miili 10 fagaatti
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Namoota walitti qabaa jiraSadarkaa 3
- Duke University Medical Center, Durham
- University of North Carolina, Chapel Hill, Chapel Hill · Miili 10 fagaatti
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Namoota walitti qabaa jira
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · Miili 10 fagaatti
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
Namoota walitti qabaa jiraSadarkaa 2
- Lineberger Cancer, Chapel Hill · Miili 10 fagaatti
Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
Namoota walitti qabaa jira
- 2400 Pratt Street, Durham
Implementation of an Oral Chemotherapy Adherence Intervention
Namoota walitti qabaa jira
- UNC Chapel Hill, Chapel Hill · Miili 10 fagaatti
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Namoota walitti qabaa jiraSadarkaa 1
- University of North Carolina, Chapel Hill · Miili 10 fagaatti
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Namoota walitti qabaa jiraSadarkaa 1/2
- Duke University Medical Center, Duke Cancer Center, Durham
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Namoota walitti qabaa jiraSadarkaa 1
- Duke Blood Cancer Center, Durham
HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
- Duke University Health System, Durham
Qorannoo Dukkana Dhiigaa magaalota biroo keessatti
- Houston, TXQorannoo 46
- New York City, NYQorannoo 26
- Boston, MAQorannoo 25
- Washington, DCQorannoo 19
- Baltimore, MDQorannoo 18
- Seattle, WAQorannoo 18
- Los Angeles, CAQorannoo 17
- Chicago, ILQorannoo 15
- Philadelphia, PAQorannoo 14
- Atlanta, GAQorannoo 13
- Nashville, TNQorannoo 13
- Edison, NJQorannoo 13
Qorannoo biroo Durham keessatti
- Saree OljooQorannoo 63
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 39
- Myeloma Baay’eeQorannoo 37
- Kansara MetastatikiiQorannoo 33
- Leukemia Myeloidii HamaaQorannoo 33
- Dhibee QaraQorannoo 32
- Kansarii ProstateQorannoo 32
- Kansarii ColorectalQorannoo 28
- Luukemiya Limfoositiikii KeessummaaQorannoo 27
- Kansarii OvariiQorannoo 27
- Cufama OnneeQorannoo 26
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.